Suchergebnisse
ePlus Q1 Earnings Call Highlights
Key Points
- Interested in ePlus inc.? Here are five stocks we like better.
- Revenue rose modestly, but profitability declined: Fiscal Q1 2027 net sales increased 1% to $649.1 million, while
Precigen Q2 Earnings Call Highlights
Key Points
- Interested in Precigen, Inc.? Here are five stocks we like better.
- PAPZIMEOS drove a major commercial acceleration: Second-quarter revenue reached $53.1 million, up more than 145%
Paylocity Q4 Earnings Call Highlights
Key Points
- Interested in Paylocity Holding Corporation? Here are five stocks we like better.
- Paylocity delivered solid fiscal 2026 results: Total revenue rose 11% to approximately $1.8 billion
Pacira BioSciences Q2 Earnings Call Highlights
Key Points
- Interested in Pacira BioSciences, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 6% to $192.4 million, driven by EXPAREL, ZILRETTA and iovera° sales
Upstart Q2 Earnings Call Highlights
Key Points
- Interested in Upstart Holdings, Inc.? Here are five stocks we like better.
- Upstart delivered strong Q2 growth and returned to profitability: Originations rose 50% year over year to
Tigo Energy Q2 Earnings Call Highlights
Key Points
- Interested in Tigo Energy, Inc.? Here are five stocks we like better.
- Q2 revenue rose 5.6% year over year to $25.4 million, but missed expectations as residential solar markets
Travere Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Travere Therapeutics, Inc.? Here are five stocks we like better.
- Record FILSPARI performance: Travere reported $169.6 million in total second-quarter revenue
TransMedics Group Q2 Earnings Call Highlights
Key Points
- Interested in TransMedics Group, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 21% year over year to approximately $190 million, driven by 28% liver
Latham Group Q2 Earnings Call Highlights
Key Points
- Interested in Latham Group, Inc.? Here are five stocks we like better.
- Q2 sales grew 14% year over year to $197 million, driven by 23% growth in in-ground pools, demand for fiberglass
Suja Life Q2 Earnings Call Highlights
Key Points
- Interested in Suja Life, Inc.? Here are five stocks we like better.
- Q2 sales rose 11.6% to $83.9 million, while adjusted EBITDA jumped 50% to $14.6 million and the margin expanded to
Silver Standard Resources Q2 Earnings Call Highlights
Key Points
- Interested in Silver Standard Resources Inc.? Here are five stocks we like better.
- Strong balance sheet and shareholder returns: SSR Mining received approximately $1.5 billion from
SpaceX Q2 Earnings Call Highlights
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- SpaceX reported strong Q2 growth: Revenue rose 92% year over year to $7.8 billion, while adjusted EBITDA increased 191% to
Syndax Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Syndax Pharmaceuticals, Inc.? Here are five stocks we like better.
- Syndax’s Q2 revenue rose 92% year over year to $72.8 million, driven by Revuforj revenue of $54.7
Coupang Q2 Earnings Call Highlights
Key Points
- Interested in Coupang, Inc.? Here are five stocks we like better.
- Revenue growth accelerated: Coupang’s Q2 revenue rose 4% year over year to $8.9 billion, or 10% in constant currency
Compass Q2 Earnings Call Highlights
Key Points
- Interested in Compass, Inc.? Here are five stocks we like better.
- Record Q2 performance: Compass reported $4.3 billion in revenue, up 14.3% pro forma, and $363 million in adjusted
Cummins Q2 Earnings Call Highlights
Key Points
- Interested in Cummins Inc.? Here are five stocks we like better.
- Cummins reported record Q2 2026 results, with revenue up 9% to $9.5 billion and EBITDA reaching $1.7 billion. The
Chatham Lodging Trust Q2 Earnings Call Highlights
Key Points
- Interested in Chatham Lodging Trust (REIT)? Here are five stocks we like better.
- Chatham Lodging Trust raised its 2026 outlook after second-quarter results exceeded expectations
Bio-Rad Laboratories Q2 Earnings Call Highlights
Key Points
- Interested in Bio-Rad Laboratories, Inc.? Here are five stocks we like better.
- Second-quarter revenue was essentially flat at approximately $651 million, while currency-neutral sales
Arista Networks Q2 Earnings Call Highlights
Key Points
- Interested in Arista Networks, Inc.? Here are five stocks we like better.
- Strong growth prompted a higher outlook: Arista’s second-quarter revenue surpassed $3 billion, up 37.7%
American Well Q2 Earnings Call Highlights
Key Points
- Interested in American Well Corporation? Here are five stocks we like better.
- Amwell’s second-quarter revenue fell 26.6% to $52 million, but its adjusted EBITDA loss narrowed to

